You are here » Home » Companies » Company Overview » Fermenta Biotech Ltd

Fermenta Biotech Ltd.

BSE: 506414	Sector: Health care
NSE: N.A.	ISIN Code: INE225B01021

BSE 00:00 | 22 Oct

312.75

-3.60
(-1.14%)

OPEN

318.00

HIGH

322.25

LOW

312.00

NSE 05:30 | 01 Jan

Fermenta Biotech Ltd

Add to Watchlist | Add to Portfolio

OPEN	318.00
PREVIOUS CLOSE	316.35
VOLUME	18898
52-Week high	370.00
52-Week low	249.00
P/E	19.00
Mkt Cap.(Rs cr)	921
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

OPEN	318.00
CLOSE	316.35
VOLUME	18898
52-Week high	370.00
52-Week low	249.00
P/E	19.00
Mkt Cap.(Rs cr)	921
Buy Price	0.00
Buy Qty	0.00
Sell Price	0.00
Sell Qty	0.00

Click here for interactive graph

Fermenta Biotech Ltd. (FERMENTABIOTEC) - News Sector

Pfizer says its Covid vaccine is 91% effective in kids of ages 5 to 11

10.56 pm | 22 Oct 2021 | Bloomberg

The efficacy result is based on a trial of about 2,250 children, according to the briefing documents
Biocon net rises 11% in Q2 to Rs 188 cr, revenue up 10% at Rs 1,945 cr

11.52 am | 22 Oct 2021 | Business Standard

Revenue growth was primarily driven by good performance of its research services and biosimilars business segments
Three trading ideas by Ajit Mishra: Buy Adani Ports, Federal Bank; sell DRL

8.27 am | 20 Oct 2021 | Business Standard

We're seeing noticeable traction in the banking pack and Federal Bank has recently witnessed a breakout from a consolidation range
Q2 preview: Non-Covid revenues to hint at normalisation for healthcare cos

10.55 pm | 17 Oct 2021 | Business Standard

Companies may, however, report sequential drop in numbers as Q1FY22 coincided with outbreak of second Covid wave, say brokerages
Sun Pharma hits over 5-yr high on hopes of robust revenue growth in Q2

3.10 pm | 13 Oct 2021 | Business Standard

Motilal Oswal Securities remains positive on Sun Pharma due to investments in the global Specialty portfolio improving overall profitability
Piramal Ent dips 5% on profit booking on demerger plan of pharma biz

10.50 am | 8 Oct 2021 | Business Standard

Shareholders of Piramal Enterprises (PEL) will get four shares of Piramal Pharma for every one share in PEL, in addition to their existing holding in ...
Demerger to give a push to both pharma and financial services: Ajay Piramal

3.04 am | 8 Oct 2021 | Business Standard

In a Q&A, the Chairman of Piramal Group talks about the prospects of both businesses, the rationale for the demerger and how supply side issues are im...
Demerger could fetch higher valuations for Piramal Pharma

1.27 am | 8 Oct 2021 | Business Standard

The company is focussing on growth and is scouting for more acquisitions
M-cap of 2 demerged entities could exceed Piramal's by 10-15%: Analysts

1.23 am | 8 Oct 2021 | Business Standard

Analysts say the demerger will make it easier for investors to value the two companies
Piramal Enterprises board approves scheme for pharma business demerger

5.52 pm | 7 Oct 2021 | Press Trust of India

Piramal Enterprises said shareholders will be issued 4 shares in demerged entity for every 1 held in Piramal Enterprises
SBI Card, Laurus Labs, Chambal Fert rally up to 10% on F&O inclusion boost

11.49 am | 7 Oct 2021 | Business Standard

Firstsource Solutions, Whirlpool of India, Birla Soft and Gujarat State Petronet will also be included in F&O segment w.e.f. October 29, 2021
Stocks to watch: RIL, ZEEL, Sobha, Lupin, Nazar Tech, Titan, Inox Wind

8.51 am | 7 Oct 2021 | Business Standard

Tata group firm Titan on Wednesday said it has witnessed a strong recovery in demand in the July-September quarter
Cipla to sell Eli Lilly's insulin products Humalog, Trulicity in India

1.02 am | 5 Oct 2021 | Business Standard

Only 3 firms - Novo Nordisk, Sanofi, and Eli Lilly - supply insulin to patients in the US. These three companies, commonly called the 'Big Three', con...
Divis Labs surges 10%, hits record high in Monday's session; here's why

11.05 am | 4 Oct 2021 | Business Standard

Merck & Co's Covid-19 antiviral pill, Molnupiravir, reduced the risk of hospitalisation or death by 50 per cent
N Govindarajan steps down as Aurobindo Pharma managing director

11.19 pm | 1 Oct 2021 | Business Standard

Govindarajan has decided to step down due to "personal reasons", Aurobindo Pharma said in a regulatory filing
DHFL acquisition to see Piramal Enterprises sharpen its retail focus

1.43 am | 30 Sep 2021 | Business Standard

Completes acquisition; pays Rs 34,250 cr to creditors
PE firm KKR affiliate sells part of its stake in Max Healthcare

12.57 am | 30 Sep 2021 | Business Standard

The shares were sold by Kayak Investment holdings, an affiliate of the private equity firm KKR for Rs 350 per share
Will step down from Tata board if there's a conflict, says Ajay Piramal

12.44 am | 30 Sep 2021 | Business Standard

In an interview, Piramal Group chairman said he would not hesitate to step down from Tata Sons board if there is a sense of conflict of interest after...
This SME pharma stock has zoomed 108% thus far in September

1.56 pm | 29 Sep 2021 | Business Standard

In past three months, Kwality Pharmaceuticals has zoomed 398 per cent, as compared to 12.8 per cent rise in the S&P BSE Sensex on the back of improved...
Sun Pharma gains 4% in 2 days after launching cough syrup Chericof 12

12.10 pm | 29 Sep 2021 | Business Standard

Chericof 12, the first prescription cough syrup in India which gives relief for up to 12 hours, is manufactured using Polistirex technology for sustai...